Back to Search Start Over

Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

Authors :
Isabel Hodl
Ana González-Pinto
Rasmus Wentzer Licht
Nina Bonkat
Bruno Etain
Frederike T. Fellendorf
Jan Scott
Lars Vedel Kessing
Veerle Bergink
Marcella Rietschel
Trine Vik Lagerberg
Chantal Henry
Tomas Hajek
Mirko Manchia
Aysegul Yildiz
Ralph Kupka
Mikael Landén
Phillip Ritter
Nina Dalkner
Guy M. Goodwin
Eva Z. Reininghaus
Alessio Squassina
René Ernst Nieslen
Gunnar Morken
Andreas Reif
Eduard Vieta
Christoph U. Correll
Andreas Bechdolf
Michael Bauer
Mónica Martínez-Cengotitabengoa
Ole A. Andreassen
Andrea Fagiolini
Thomas G. Schulze
Etain, Bruno
Medical University Graz
University of Cagliari
Dalhousie University [Halifax]
University of Barcelona
Frankfurt University Hospital
National Institute of Mental Health [Klecany, Czech Republic] (NIMH)
University of Gothenburg (GU)
Karolinska Institutet [Stockholm]
Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Hofstra University [Hempstead]
Newcastle University [Newcastle]
Optimisation thérapeutique en Neuropsychopharmacologie (OPTeN (UMR_S_1144 / U1144))
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
Département Médico-Universitaire Neurosciences [Sorbonne Université] (DMU Neurosciences)
CHU Charles Foix [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Tenon [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Trousseau [APHP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Rothschild [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Saint-Antoine [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Hôpital Lariboisière-Fernand-Widal [APHP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Heidelberg University
Icahn School of Medicine at Mount Sinai [New York] (MSSM)
Erasmus University Medical Center [Rotterdam] (Erasmus MC)
University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU)
University of East Anglia [Norwich] (UEA)
University of Copenhagen = Københavns Universitet (UCPH)
Università degli Studi di Siena = University of Siena (UNISI)
Technische Universität Dresden = Dresden University of Technology (TU Dresden)
University of Oxford
Bioaraba Health Research Institute
Vrije Universiteit Amsterdam [Amsterdam] (VU)
Ludwig-Maximilians University [Munich] (LMU)
Oslo University Hospital [Oslo]
Dokuz Eylül Üniversitesi = Dokuz Eylül University [Izmir] (DEÜ)
GHU Paris Psychiatrie et Neurosciences
Norwegian University of Science and Technology (NTNU)
Aalborg University [Denmark] (AAU)
University of Oslo (UiO)
Source :
Addi. Archivo Digital para la Docencia y la Investigación, instname, European Neuropsychopharmacology, Reininghaus, E Z, Manchia, M, Dalkner, N, Bonkat, N, Squassina, A, Hodl, I, Vieta, E, Reif, A, Hajek, T, Landén, M, Correll, C U, Scott, J, Etain, B, Rietschel, M, Bergink, V, Martinez-Cengotitabengoa, M, Kessing, L V, Fagiolini, A, Bauer, M, Goodwin, G, Gonzalez-Pinto, A, Kupka, R W, Schulze, T G, Lagerberg, T V, Yildiz, A, Henry, C, Morken, G, Ritter, P, Nieslen, R E, Licht, R W, Bechdolf, A, Andreassen, O A & Fellendorf, F T 2022, ' Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic-a systematic review ', European Neuropsychopharmacology, vol. 54, pp. 90-99 . https://doi.org/10.1016/j.euroneuro.2021.09.001, European Neuropsychopharmacology, 2022, 54, pp.90-99. ⟨10.1016/j.euroneuro.2021.09.001⟩
Publication Year :
2022

Abstract

Bipolar disorder (BD) might be associated with higher infection rates of coronavirus disease (COVID-19) which in turn could result in worsening the clinical course and outcome. This may be due to a high prevalence of somatic comorbidities and an increased risk of delays in and poorer treatment of somatic disease in patients with severe mental illness in general. Vaccination is the most important public health intervention to tackle the ongoing pandemic. We undertook a systematic review regarding the data on vaccinations in individuals with BD. Proportion of prevalence rates, efficacy and specific side effects of vaccinations and in individuals with BD were searched. Results show that only five studies have investigated vaccinations in individuals with BD, which substantially limits the interpretation of overall findings. Studies on antibody production after vaccinations in BD are very limited and results are inconsistent. Also, the evidence-based science on side effects of vaccinations in individuals with BD so far is poor. (c) 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )

Details

Language :
English
ISSN :
0924977X and 18737862
Database :
OpenAIRE
Journal :
Addi. Archivo Digital para la Docencia y la Investigación, instname, European Neuropsychopharmacology, Reininghaus, E Z, Manchia, M, Dalkner, N, Bonkat, N, Squassina, A, Hodl, I, Vieta, E, Reif, A, Hajek, T, Landén, M, Correll, C U, Scott, J, Etain, B, Rietschel, M, Bergink, V, Martinez-Cengotitabengoa, M, Kessing, L V, Fagiolini, A, Bauer, M, Goodwin, G, Gonzalez-Pinto, A, Kupka, R W, Schulze, T G, Lagerberg, T V, Yildiz, A, Henry, C, Morken, G, Ritter, P, Nieslen, R E, Licht, R W, Bechdolf, A, Andreassen, O A & Fellendorf, F T 2022, ' Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic-a systematic review ', European Neuropsychopharmacology, vol. 54, pp. 90-99 . https://doi.org/10.1016/j.euroneuro.2021.09.001, European Neuropsychopharmacology, 2022, 54, pp.90-99. ⟨10.1016/j.euroneuro.2021.09.001⟩
Accession number :
edsair.doi.dedup.....34f359971aae139b464cee1385604f72
Full Text :
https://doi.org/10.1016/j.euroneuro.2021.09.001